A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer
Clinical trial NCT02599363 · COMPLETED
Trial details
- NCT number
- NCT02599363
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2019-03-12
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.